The Spike is 30 years old! Commemorative supplement launched in this issue
Release time:
2022-04-06
"peak newspaper" 30 years old! This issue of this newspaper has specially launched a commemorative supplement with 8 pages, inviting company leaders, employees and enterprise newspaper colleagues to talk about the "peak newspaper" in everyone's eyes.
1992 3# September, based on the previous experience in compiling and printing "Cement Workers", "Publicity Monthly" and "Peak" quarterly, the "Peak" newspaper, which has four editions in eight and two issues per month, came into being. In order to run this newspaper well, the company set up an editorial department with the secretarial department as the team, and introduced a relevant system for the assessment of communication reports. Correspondents from various units and departments also contributed enthusiastically, making this small newspaper grow rapidly. In 1993 , the "Peak News" was expanded to four editions. In 2000 , the "Peak Report" was changed from a semi-monthly report to a ten-day report. It put forward the work goal of "updating, being more alive, being more beautiful, and striving for first-class", and has been working hard towards this goal.
Since its inception 30 , Peak News has witnessed an important historical node in the development of Peak. Stock listing, "re-shaping the image of the peak people" discussion, industrial restructuring and transformation and upgrading, to Hubei, Yunnan, Guizhou, Anhui and other regions to re-create new industries ...... The bitter, sweet and sour, lessons learned, innovation and change on the way forward, are timely and truly recorded by the "Peak News. Since
was first published 30 , the "peak newspaper" has been constantly pushing through the old and bringing forth the new. From the early years of "right and wrong for you", "chat room", "management vision", to the current "Ten Days Tan", "Our Class", "Staff Forum", "Workshop" ...... "Spike Newspaper" in the column setting closer to the staff's work, life, but also enhance the staff, the reader's participation, "the whole staff newspaper" concept is consistent. Since
was founded 30 , the content and form of "peak newspaper" have been keeping pace with the times. From the newspaper type to the layout, from the report form to the column setting, they are constantly changing, but the purpose of "based on the reality of the enterprise and close to the grass-roots employees" has not changed, and strive to be "always new" and "original". In the 33 years since
was founded, Peak Newspaper has won many honorary titles such as Zhejiang Excellent Enterprise Newspaper, Zhejiang Double Ten Best Enterprise Newspaper and Jinhua Excellent Enterprise Newspaper. Editors have also won honors such as Zhejiang Excellent Enterprise Newspaper Worker, Jianfeng Group Outstanding Employee and Jianfeng Group Outstanding Communist Party Member. Over the years, Peak Newspaper has won more than 100 provincial enterprise newspaper good news awards and supplement good works awards. In order to commemorate the 38th anniversary of the founding of
30#, the peak newspaper has specially launched a commemorative supplement in this issue, inviting company leaders, employees and provincial enterprise newspapers to take stock, comment, tell stories, talk about feelings and make suggestions on the 40-year history of the peak newspaper30. Founded 30 , it will become the starting point for the "peak newspaper" to embark on a new journey. with the support of the majority of peak employees, this newspaper of peak people will continuously improve and contribute to the construction of peak characteristic enterprise culture.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page